everolimus
chemical compound
Facts
21 properties- Instance of
- type of chemical entity
- Subclass of
- LSM-4258[5]
- Has use
- medication[6]
- Active ingredient in
- Afinitor, Votubia, Zortress
- Canonical SMILES
- CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC[3]
- Chemical formula
- C₅₃H₈₃NO₁₄[4]
- Defined daily dose
- 1.5 mg
- Has active ingredient
- Everolimus
- Has parts
- carbon
- Isomeric SMILES
- C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC
- Legal status (medicine)
- boxed warning
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*
- Mass
- 957.581 Da
- Medical condition treated
- benign neoplasm of brain, neuroendocrine carcinoma, kidney angiomyolipoma, renal clear cell carcinoma, carcinoid syndrome, renal cell carcinoma, carcinoid tumor, acute myeloid leukemia, low-grade astrocytoma, islet cell carcinoma, tuberous sclerosis 1, angiomyolipoma
+7 more
kidney cancer, lymphoma, diffuse large B-cell lymphoma, small intestine carcinoma, neuroendocrine tumor (2009–present), renal cell carcinoma (2009–present), breast cancer (2009–present) - Physically interacts with
- mechanistic target of rapamycin kinase[2]
- Pregnancy category
- US pregnancy category D
- Significant drug interaction
- idelalisib
- Stereoisomer of
- LSM-5313
- Subject has role
- protein kinase inhibitors, xenobiotic-transporting ATPase inhibitor, antineoplastic, immunosuppressive drug
- World Health Organisation international non-proprietary name
- everolimus
🏷️ Also known as
en RAD001
en SDZ-RAD
en 40-O-(2-hydroxyethyl)-rapamycin
en 42-O-(2-hydroxyethyl)rapamycin
en everolimus
ar إيفيروليموس
de RAD-001
fa اورولیمس
fi everolimuusi
fr évérolimus
hu everolimusz
it everolimus
ja アフィニトール
ja エベロリムス
ja サーティカン
pl ewerolimus
pl RAD-001
pt Afinitor
pt everolimo
ru эверолимус
🔖 Identifiers · 38
- OpenAlex ID
- C2779699572
- CAS Registry Number
- 159351-69-6
- ChEBI ID
- 68478
- ChEMBL ID
- CHEMBL1908360
- ChemSpider ID
- 21106307
- DSSTOX compound identifier
- DTXCID8020599
- DSSTox substance ID
- DTXSID0040599
- DeCS ID
- 55896
- DrugBank ID
- DB01590
- DrugCentral ID
- 1118
- EC number
- 621-003-9
Show all 38 identifiers +26
- ECHA Substance Infocard ID
- 100.149.896
- Freebase ID
- /m/02m34c
- Guide to Pharmacology Ligand ID
- 5889
- HSDB ID
- 8255
- Human Metabolome Database ID
- HMDB0015529
- InChIKey
- HKVAMNSJSFKALM-GKUWKFKPSA-N
- KEGG ID
- D02714
- LiverTox ID
- Everolimus
- MeSH descriptor ID
- D000068338
- MeSH tree code
- D02.540.505.760.500
- MedlinePlus drug identifier
- a609032
- Microsoft Academic ID (discontinued)
- 2779699572
- NDF-RT ID
- N0000178379
- National Drug Code
- 17088-0149, 17088-0247, 17088-0306, 52076-6253, 65727-046, 65727-063, 0093-7766, 51991-380, 51991-821, 51991-822, 51991-985, 59651-931
+38 more
59651-933, 60219-2279, 67877-718, 70377-091, 17088-0135, 62227-019, 51991-991, 51991-992, 63850-0060, 63850-0063, 70377-070, 70377-090, 72603-256, 82293-033, 17088-0290, 49884-125, 51991-379, 63850-0107, 70377-013, 17088-0114, 71796-012, 49884-283, 59651-932, 59651-934, 60219-2280, 63850-0064, 70377-069, 0054-0480, 72603-254, 72603-257, 17088-0261, 52076-6234, 54893-0126, 0093-7769, 49884-159, 70377-071, 0054-0604, 72603-255 - PatientsLikeMe treatment ID
- everolimus
- Probes And Drugs ID
- PD004083
- PubChem CID
- 6442177
- RxNorm CUI
- 141704
- SureChEMBL ID
- 4378
- UK Parliament thesaurus ID
- 418338
- UMLS CUI
- C0541315
- UNII
- 9HW64Q8G6G
- UniChem compound ID
- 1077088
- WikiProjectMed ID
- Everolimus
- World Health Organisation international non-proprietary name numeric ID
- 7863
🔗 Connections
← Drug or therapy used for treatment 15
Medical condition treated 12
Subject has role 3
Has part(s) 1
Has use 1
Legal status (medicine) 1
Physically interacts with 1
Significant drug interaction 1
← Physically interacts with 1
← Significant drug interaction 1
Press Enter · cited answer in seconds
0 sources
Summary
everolimus is a type of chemical entity[1].